Tengion Inc. Provides Business Update and Reports First Quarter 2013 Financial Results
5/15/2013 7:37:02 AM
More...
|
Tengion Inc. Receives MPA Approval of CTA for Neo-Kidney Augment Phase 1 Trial in Sweden
4/1/2013 9:57:47 AM
More...
|
Tengion Inc. Provides Business Update and Reports Fourth Quarter and Full Year 2012 Financial Results
3/18/2013 6:51:05 AM
More...
|
Tengion Inc. to Host Conference Call to Provide a Business Update and Report Fourth Quarter and Full Year 2012 Financial Results on March 18, 2013
3/12/2013 9:53:07 AM
More...
|
Tengion Inc. to Present at 25th Annual ROTH Conference
3/12/2013 7:31:16 AM
More...
|
Tengion Inc. to Present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/5/2013 6:59:56 AM
More...
|
Tengion Inc. Announces Clinical Progress for Neo-Urinary Conduit™ Phase 1 Trial and Regulatory Advance for Neo-Kidney Augment™
1/31/2013 8:30:42 AM
More...
|
Tengion Inc. Announces Change to Board of Directors
12/21/2012 6:35:10 AM
More...
|
Tengion Inc. Provides Business Update and Reports Third Quarter 2012 Financial Results
11/13/2012 10:06:55 AM
More...
|
Tengion Inc. Issued Additional Notice of Allowance for U.S. Patent Application Covering Cell-Scaffold Regeneration for Its Neo-Urinary Conduit™ Product Candidate
11/9/2012 2:14:37 PM
More...
|
|